TENX Tenax Therapeutics

• $6.6M bought by 7 insiders
• None no sales outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
   Buy
   $1.5M 922,849 shares at $1.59 +14% to stake
   Traded Oct 19–21 Filed Oct 21
   ↗
3. Declan Doogan Director
   Buy
   $102K 53,000 shares at $1.92 +2331% to stake
   Traded Sep 16 Filed Sep 17
   ↗
4. Christopher Thomas Giordano CEO
   Buy
   $20K 10,850 shares at $1.85 +96% to stake
   Traded Sep 11–15 Filed Sep 15
   ↗
5. Thomas R Staab II CFO
   Buy
   $11K 5,675 shares at $1.94 +57% to stake
   Traded Sep 11 Filed Sep 15
   ↗
6. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
   Buy
   $1.6M 900,000 shares at $1.78 +16% to stake
   Traded Sep 3 Filed Sep 8
   ↗
7. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
   Buy
   $1.4M 770,333 shares at $1.79 +16% to stake
   Traded Aug 31–Sep 2 Filed Sep 2
   ↗
8. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
   Buy
   $1.8M 1,025,867 shares at $1.77 +27% to stake
   Traded Aug 20–24 Filed Aug 24
   ↗
9. Stuart Rich Chief Medical Officer
   Buy
   $51K 5,000 shares at $10.16
   Traded Dec 8–9 Filed Dec 10, 2025
   ↗
10. Stuart Rich Chief Medical Officer
    Buy
    $46K 5,000 shares at $9.12
    Traded Dec 2–4 Filed Dec 5, 2025
    ↗
11. Christopher Thomas Giordano CEO
    Buy
    $20K 2,605 shares at $7.68 New stake
    Traded Nov 18–20 Filed Nov 20, 2025
    ↗
12. June Sherie Almenoff Director
    Buy
    $15K 1,993 shares at $7.50 New stake
    Traded Nov 17–18 Filed Nov 20, 2025
    ↗
13. Thomas McGauley CFO
    Buy
    $58K 8,000 shares at $7.27
    Traded Nov 17, 2025 Filed Nov 19, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises and 1 stock grant.